Closing in on biomarkers – interview with PRISM’s Martien Kas

Press/Media: ResearchProfessional

Description

The PRISM project (Psychiatric Ratings using Intermediate Stratified Markers), is a joint Industry-Academia project to relate biological characteristics to clinical diagnosis in mental health. The first part of the project, PRISM1, was initiated in 2016. PRISM2 was recently funded by the EU’s Innovative Medicines Initiative to build on the findings from the original PRISM project.

Period9-Dec-2021

Media contributions

1

Media contributions

  • TitleClosing in on biomarkers – interview with PRISM’s Martien Kas
    Degree of recognitionInternational
    Media name/outletECNP Newsbulletin
    Media typeWeb
    Country/TerritoryNetherlands
    Date09/12/2021
    DescriptionThe PRISM project (Psychiatric Ratings using Intermediate Stratified Markers), is a joint Industry-Academia project to relate biological characteristics to clinical diagnosis in mental health. The first part of the project, PRISM1, was initiated in 2016. PRISM2 was recently funded by the EU’s Innovative Medicines Initiative to build on the findings from the original PRISM project.
    Producer/AuthorECNP
    URL https://www.ecnp.eu/-/media/3A45CD1BE3EA45F88BD9732AC9EBADEB.pdf
    PersonsMartien Kas